Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

CVS Health Q3 2026 Results: Turns Profitable, Net Income $2.17B

CVS Health reported total revenues of $108.4 billion for the third quarter of 2026, up from $102.9 billion in the prior year. The company returned to profitability with a net income of $2.17 billion compared to a net loss of $3.98 billion in Q3 2025, which had been impacted by a $5.7 billion goodwill impairment charge.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue108,399.0102,871.0
Profit before tax2,849.0-3,482.0
Net income2,172.0-3,975.0
EPS (diluted, $ a share)$1.68$-3.13

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Revenue, year on year+5.4%
Operating margin3.3%
Source

10-Q filed with the SEC, NYSE: CVS. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

CVS Health Corp: key numbers

Share price
$88.59Close, Nov 16
Market cap
$113B
Shares outstanding
1.28BLatest SEC cover page
Sector
Trade & Services
Industry
Retail-Drug Stores and Proprietary StoresSIC 5912

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from CVS Health Corp

All →
4:42 PM ET Form 4
Insider Buying

CVS Health EVP and Group President Prem S. Shah Buys $2M of Stock

Prem S. Shah, EVP and Group President, bought 23,855 shares of CVS Health Corp at $83.89 a share, worth $2M in total on Nov 6, 2026. Shares held after the trade: 88,516 (+36.9%).

Value
$2M
Shares
23,855
Price
$83.89
Role
EVP and Group President
Holding change
+36.9%
Trade date
Nov 6, 2026
6:34 AM ET 8-K
Divestiture

CVS Health Divestiture

CVS Health announced its intention to separate into two independent, publicly traded companies: a healthcare solutions company (including Aetna and Caremark) and a national retail pharmacy company (CVS Pharmacy). The transaction is expected to be completed in the first half of 2028 and is intended to be tax-free for the company and its shareholders.

6:32 AM ET 8-K
Financial Results

CVS Health Financial Results

CVS Health reported third-quarter 2026 total revenues of $108.4 billion, a 5.4% year-over-year increase, and GAAP diluted EPS of $1.68. The company raised its full-year 2026 Adjusted EPS guidance to at least $8.20, citing strong performance across all operating segments and execution of its margin recovery plan in the Health Care Benefits segment.

Term
Q3 2026

“Our colleagues build trust every day through delivering quality health care rooted in our purpose - to simplify health care one person, one family and one community at a time. Through their continued dedication, each of our businesses delivered another quarter of strong results. We continue to advance our strategy by improving the consumer experience, lowering health care costs, and connecting care for the people we serve.”

David Joyner, CVS Health Chairman and CEO

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.